FreshPatents.com Logo


new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)


Similar
Filing Names

Incyte Corporation
Incyte Corporation A Delaware Corporation
Incyte Corporationn A Delaware Corporation

Popular
Companies


Web
Adobe patents
Akamai patents
Amazon patents
Apple patents
Ebay patents
Facebook patents
Google patents
IBM patents
Linkedin patents
Microsoft patents
Oracle patents
Red Hat patents
Yahoo patents

Food/Health
Adidas
Nike patents
Pfizer patents
Monsanto patents
Medtronic patents
Kraft patents

Transportation
Boeing patents
Tesla Motors patents

Telecom
Qualcomm patents
Motorola patents
Nokia patents
RIMM patents

Industrial/Electronics
AMD
Applied Materials
Seagate patents
General Electric
Caterpillar patents
Samsung
Wal-mart patents

Ticker Symbols

Incyte Corporation patents


      
Recent patent applications related to Incyte Corporation. Incyte Corporation is listed as an Agent/Assignee. Note: Incyte Corporation may have other listings under different names/spellings. We're not affiliated with Incyte Corporation, we're just tracking patents.

ARCHIVE: New 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Incyte Corporation-related inventors



Search recent Press Releases: Incyte Corporation-related press releases
Count Application # Date Incyte Corporation patents (updated weekly) - BOOKMARK this page
12010002252201/28/10Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
22014027503009/18/14 new patent  Tricyclic heterocycles as bet protein inhibitors
32014027503109/18/14 new patent  Piperidin-4-yl azetidine derivatives as jak1 inhibitors
42014027512709/18/14 new patent  Substituted heteroaryl fused derivatives as pi3k inhibitors
52014025694109/11/14Processes and intermediates for making a jak inhibitor
62014024913209/04/14Use of pyrazolopyrimidine derivatives for the treatment of pi3k-delta related disorders
72014024208608/28/14Polynucleotides encoding signal peptide-containing molecules
82014024330808/28/14Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
92014024336008/28/14Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
102014022727508/14/14Methods of treating and diagnosing pancreatitis
112014022727808/14/14Antibodies to human signal peptide-containing proteins
122014022834608/14/14Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
132014022137908/07/14N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
142014020021607/17/14Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitors
152014020022707/17/14Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors
162014018753007/03/14Aza spiro alkane derivatives as inhibitors of metalloproteases
172014017140506/19/14Fused pyrazoles as fgfr inhibitors
182014017140906/19/14Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
192014015528806/05/14Methods for diagnosing cancer
202014015537706/05/143-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
212014015540406/05/14Piperazinylpiperidine derivatives as chemokine receptor antagonists
222014013535005/15/14Sustained-release dosage forms of ruxolitinib
232014013535005/15/14Sustained-release dosage forms of ruxolitinib
242014012119805/01/14Tricyclic fused thiophene derivatives as jak inhibitors
252014012122205/01/14Pyrimidinones as pi3k inhibitors
262014012119805/01/14Tricyclic fused thiophene derivatives as jak inhibitors
272014012122205/01/14Pyrimidinones as pi3k inhibitors
282014006644803/06/14Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
292014006644803/06/14Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
302014005690602/27/14Secreted proteins
312014005791202/27/14Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
322014004581402/13/14Pyrazine derivatives as fgfr inhibitors
332014003134401/30/14Azepine inhibitors of janus kinases
342014002366301/23/141,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
352014001837401/16/14Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
362014000516601/02/14Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
372014000521001/02/14Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
382013034515712/26/13Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
392013034522412/26/13Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
402013032451512/05/13Imidazotriazines and imidazopyrimidines as kinase inhibitors
412013025319009/26/13Processes for preparing jak inhibitors and related intermediate compounds
422013025319109/26/13Processes for preparing jak inhibitors and related intermediate compounds
432013025319309/26/13Processes for preparing jak inhibitors and related intermediate compounds
442013024378109/19/13Signal peptide-containing proteins
452013024492709/19/13Polynucleotides encoding signal peptide-containing molecules
462013024499909/19/13Substituted heterocyclic compounds
472013022476908/29/13Methods of using chemokine panec-1 antibodies
482013022555608/29/13Azetidine and cyclobutane derivatives as jak inhibitors
492013022476908/29/13Methods of using chemokine panec-1 antibodies
502013022555608/29/13Azetidine and cyclobutane derivatives as jak inhibitors
512013019025007/25/13Polynucleotides encoding human signal peptide-containing proteins
522013019025007/25/13Polynucleotides encoding human signal peptide-containing proteins
532013017759007/11/13N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
542013017759007/11/13N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
552013013768105/30/13Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
562013013768105/30/13Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
572013012324605/16/13Modulators of indoleamine 2,3-dioxygenase and methods of using the same
582013012324605/16/13Modulators of indoleamine 2,3-dioxygenase and methods of using the same
592013011623005/09/133-aminopyrrolidine derivatives as modulators of chemokine receptors
602013011623005/09/133-aminopyrrolidine derivatives as modulators of chemokine receptors
612013009614404/18/13Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors
622013005894203/07/13Human beta-adrenergic receptor kinase polypeptide and methods
632013005983503/07/13Heterocyclylamines as pi3k inhibitors
642013006002603/07/13Processes and intermediates for making a jak inhibitor
652013004596302/21/13Cyclohexyl azetidine derivatives as jak inhibitors
662013001803401/17/13Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
672013001806801/17/13Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
682012032978212/27/12Azepine inhibitors of janus kinases
692012030146411/29/12Janus kinase inhibitors for treatment of dry eye and other eye related diseases
702012029591211/22/12Piperazinylpiperidine derivatives as chemokine receptor antagonists
712012027080910/25/12Human transmembrane proteins
722012012285805/17/12Lactam compounds and their use as pharmaceuticals
732012004096402/16/12N-substituted piperidines and their use as pharmaceuticals
742012003517202/09/12Purinone derivatives as hm74a agonists
752012001493701/19/12Human beta-adrenergic receptor kinase polypeptide and methods
762012001592801/19/12Amido compounds and their use as pharmaceuticals
772011025121510/13/11Macrocyclic compounds and their use as kinase inhibitors
782011021296709/01/11Imidazo[1,2-b][1,2,4]triazines as c-met inhibitors
792011020775408/25/11Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
802011013678106/09/11Imidazotriazines and imidazopyrimidines as kinase inhibitors
812011008681004/14/11Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d] pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
822011008215904/07/11Metabolites of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
832011005321703/03/11Polynucleotides encoding signal peptide-containing molecules
842010027933311/04/10Methods of treatment with antibodies to a chemokine expressed in inflamed adenoid
852010025611410/07/10Amido compounds and their use as pharmaceuticals
862010024067109/23/10Substituted heterocyclic compounds
872010020303908/12/103-aminocyclopentanecarboxamides as modulators of chemokine receptors
882010019080407/29/10Macrocyclic compounds and their use as kinase inhibitors
892010017390107/08/10Substituted heterocyclic compounds
902010013740106/03/102-methylprop anamides and their use as pharmaceuticals
912010011950305/13/103-aminocyclopentanecarboxamides as modulators of chemokine receptors
922010009961704/22/10Secreted proteins
932009031840512/24/094-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
942009029194611/26/09Lactam compounds and their use as pharmaceuticals
952009028677411/19/09Purinone derivatives as hm74a agonists
962009028677811/19/09Macrocyclic compounds and their use as kinase inhibitors
972009027468011/05/09Human phospholipases
982009023390309/17/09Azetidine and cyclobutane derivatives as jak inhibitors
992009021576608/27/09Tetracyclic inhibitors of janus kinases
1002009019788708/06/09Piperazinylpiperidine derivatives as chemokine receptor antagonists
1012009018195907/16/09Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
1022009012464905/14/09Aza spiro alkane derivatives as inhibitors of metalloproteases
1032009008844604/02/09Purinone derivatives as hm74a agonists
1042009007626903/19/09Purinone derivatives as hm74a agonists
1052012026367610/18/12Compositions, methods and kits relating to her-2 cleavage
1062012005807903/08/121,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
1072012001498901/19/12Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
1082011031147912/22/11Modulators of indoleamine 2,3-dioxygenase and methods of using the same
1092011022321009/15/11Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
1102011022415709/15/11Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
1112011017227907/14/11N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
1122011016518807/07/11N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
1132011008683504/14/11Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
1142009029880812/03/09Inhibitors of 11-beta hydroxyl steroid dehydrogenase type i and methods of using the same
1152009019786908/06/09Azepine inhibitors of janus kinases


ARCHIVE: New 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Incyte Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Incyte Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###

     SHARE
  
         


FreshNews promo